Welcome to HRS 2026

April 24-26, 2026 | Chicago, Illinois

We are delighted to invite you to join us at HRS 2026 in Chicago, Illinois, where we will showcase our proprietary CCM® therapy. Stop by booth #610, to listen to talks from world-renowned physicians and explore our product stations. Don’t miss our CCM evening event or our Heart Rhythm Theater Symposium – When GDMT and ICDS Fall Short: Integrating CCM® Therapy in Heart Failure Care.

Exhibit Hall Hours:

Friday, April 24 | 9:30 AM to 5:30 PM

Saturday, April 25 | 9:00 AM to 5:00 PM

Sunday, April 26 | 8:30 AM to 11:30 AM

Plan Your Day

6:00 - 9:30 PM CDT

CCM® Evening at Heart Rhythm 2026

Please join global thought leaders in a discussion on the role of CCM therapy in evolving management of heart failure.

Apolonia
105 E Cermak Road
Chicago, IL 60616

Kenneth A. Ellenbogen, MD, FHRS

Virgina Commonwealth University.
Richmond, VA

Devi G. Nair, MD, FHRS

St. Bernards Healthcare
Jonesboro, AR

IN BOOTH SESSIONS

Booth 610

10:00 - 10:20 AM CDT

Ambrose Panico, MD

CVMC
Mesa, AZ

From Patient Identification to Patient Access: Optimizing the CCM Pathway.

11:30 - 11:50 AM CDT

Andrew Kaplan, MD

Arizona Heart & Vascular
Glendale, AZ

Beyond the Rhythm: The EP as a Champion for Heart Failure Patients

1:00 - 1:20 PM CDT

Sameer Jamal, MD

Hackensack University Medical Center
Hackensack, NJ

Advancing CCM Program Success Through HF - EP Collaboration

2:30 - 2:50 PM CDT

Rami Kahwash, MD

The Ohio State University
Columbus, OH

Sustained Efficacy of CCM in Heart Failure Patients with Reduced or Mildly Reduced EF

12:15 - 1:15 PM CDT

Rhythm Theater Presentation:

When GDMT and ICDS Fall Short: Integrating CCM® Therapy in Heart Failure Care

Program Description:

Join us at this year’s HRS symposium for a focused, data driven discussion on one of the most pressing challenges in heart failure care. This symposium will highlight why current therapeutic options fall short despite advances in GDMT, introduce CCM? therapy as a practical and easily integrated solution alongside ICDs, and underscore the importance for symptom relief for heart failure patients. Attendees will gain insight into the evolving role of CCM in heart failure management, including the latest clinical data and trial updates. CCM? Therapy offers a promising treatment option for patients with NYHA Class III heart failure, and an ejection fraction (EF) of 25–45%, who remain symptomatic despite guideline-directed medical therapy (GDMT) and are not receiving cardiac resynchronization therapy (CRT).

Location:

Rhythm Theater 1

Lunch will be served

Program Moderator:

Niraj Varma, MA, MD, PhD, FRCP

Cleveland Clinic
Cleveland, OH

Jodie L. Hurwitz, MD, FHRS

North Texas Heart Center
Dallas, TX

Faculty

Marat Fudim, MD, MHS

Duke University
Durham, NC

 

Usman Siddiqui, MD

Advent Health
Orlando, FL

Gery Tomassoni, MD

Baptist Health
Lexington, KY

IN BOOTH SESSIONS

Booth 610

10:00 - 10:20 AM CDT

Emad Aziz, MD

Rutgers New Jersey Medical School
Newark, NJ

Clinical EP: First Report Demonstrating Freedom from Inotropic Support and Hemodynamic Insights After CCM in AHF

2:45 - 3:05 PM CDT

Benjamin D’Souza, MD

Penn Presbyterian Medical Center - University of Pennsylvania
Philadelphia, PA

Who Is the Right CCM Patient? Identification Pearls and Access Realities